Amneal Pharmaceuticals (AMRX) Assets (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded Assets of $3.78 billion in Q2 2026, up 10.3% from $3.42 billion a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Amneal Pharmaceuticals reported Assets of $3.68 billion, up 5.1% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $3.5 billion in FY2024 (+0.8%), $3.47 billion in FY2023 (-8.6%), $3.8 billion in FY2022 (-3.6%) and $3.94 billion in FY2021 (-1.7%).
- The Q2 2026 figure is the highest quarterly Assets since Q4 2022.
- On a year-over-year basis, Assets has increased for four consecutive quarters, with growth averaging 1.8% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 10.3% in Q2 2026, against a decline of 8.6% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.54 billion (Q1 2026), $3.68 billion (Q4 2025) and $3.6 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Amneal Pharmaceuticals | 6.45 Bn | 5.73 Bn | 334.51 Mn | 3.78 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.78 Bn |
| Mar 31, 2026 | 3.54 Bn |
| Dec 31, 2025 | 3.68 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.42 Bn |
| Mar 31, 2025 | 3.37 Bn |
| Dec 31, 2024 | 3.50 Bn |
| Sep 30, 2024 | 3.46 Bn |
| Jun 30, 2024 | 3.51 Bn |
| Mar 31, 2024 | 3.46 Bn |
| Dec 31, 2023 | 3.47 Bn |
| Sep 30, 2023 | 3.69 Bn |
| Jun 30, 2023 | 3.70 Bn |
| Mar 31, 2023 | 3.63 Bn |
| Dec 31, 2022 | 3.80 Bn |
| Sep 30, 2022 | 3.87 Bn |
| Jun 30, 2022 | 4.04 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 3.94 Bn |
| Sep 30, 2021 | 3.97 Bn |
API Access
Amneal Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();